Oaktree Acquisition Corp. II logo

Oaktree Acquisition Corp. II

OACC | NASDAQ
Chart Builder DCF Calculator
$10.72
$0.00 (0.00%)
At close: Oct 30, 2026, 4:00 PM ET
$10.72
$0.00 (0.00%)
After-hours: Oct 30, 2026, 4:00 PM ET

Company Profile

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

Key Executives

Name Position
Zaid Pardesi Chief Executive Officer & Director
George A. Martinez Chief Financial Officer, Principal Accounting & Principal Financial Officer
Mathew Pendo Chief Operation Officer
Oaktree Acquisition Corp. II
Oaktree Acquisition Corp. II logo
Country United States
IPO Date Dec 16, 2024
Industry Shell Companies
Sector Financial Services
Employees 3
CEO Zaid Pardesi

Contact Details

333 South Grand Avenue Los Angeles, California 90071 United States

Stock Details

Ticker Symbol OACC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0002029769
CUSIP Number G6717R104
ISIN Number KYG6717R1048
SIC Code 6770

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.